Beximco Pharma currently produces more than 300 generic medicines which are available in well over 500 different presentations and the broad portfolio encompasses all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, gastrointestinal etc.
Read More..

Life's all about staying healthy and enjoying the good things in life! However, illness is inevitable at all stages of life. In this area learn about the common health problems and how to deal with your and your family's illness.Read More

Welcome to the registered Health Professionals, to this exclusive Doctors only area. This provides you access to latest medical updates, events, guidelines and information relevant to your practice. If you are not a registered doctor please do not enter this area.Read More

As the company is incorporated in Bangladesh (not in UK), it is hereby stated that the rights of shareholders of the company may be different from the rights of shareholders in a UK incorporated company.Read More

Welcome to Beximco Pharma’s news and media center. Here in the media center you will find a range of resources including our latest and archived news releases, publication and information on our official social media, and multimedia gallery where our photo and video library.
Read More

Vibose

Voglibose

Tablet

1. What Vibose® is and what it is used for?Vibose® is the preparation of voglibose. Voglibose acts by inhibition of alpha- glucosidase, an enzyme responsible to breakdown carbohydrate and facilitate the absorption of monosaccharide, i.e. glucose, fructose. Thus, voglibose delays the absorption as well as digestion of dietary carbohydrates. Voglibose is indicated for improvement of postprandial hyperglycemia in diabetes mellitus only when diet and/or exercise or oral hyperglycemic drug or Insulin preparation in addition to diet and/or exercise does not result in adequate glycemic (Glycemic) control. The drug is taken just before meals to prevent the postprandial hyperglycemia seen in diabetics. This type of agent can be considered a drug of first choice in overweight diabetic patients

2. How to take this medicine?The medicine should be taken orally in dose of 0.2 or 0.3 g, three times daily, just before meals.

3.Who should NOT take this medication?Voglibose is contraindicated in:

4. What side effects are possible with this medication?Voglibose often causes dose-related gastrointestinal side effects such as flatulence, abdominal distension, diarrhoea, pain and hypoglycemia. A decrease in dosage and improved dietary habits may reduce these adverse effects. Hepatocellular liver damage, with jaundice and elevated serum aminotransferases may occur. Episodes of paralytic ileus in elderly diabetic patients have been reported. Intolerable dizziness with nausea and vomiting has occurred in elderly DM patients on start of therapy with Voglibose.

5. How to store Vibose®?Vibose® must be kept out of the reach and sight of children. Protect from light. Store below 30°C.